Mind Medicine (MNMD) Misses Q2 EPS by 13c

Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.50), $0.13 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Obsidian Energy Increases Syndicated Credit Facility
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal